Worldwide governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group.
July 2014 Examples of media coverage: HIV “Cleared” in Two Australian Men after Bone-Marrow Transplants– Sydney Morning Herald, July 19, 2014 HIV Said Cleared in Two Bone Marrow Transplant Patients– Bloomberg News, July 18, 2014 Cancer Treatment Clears Two Australian Patients…
July 2014 Examples of media coverage: Researchers Find New Way to Kick Out HIV from Infected Cells– Time, July 21, 2014 Temple Researchers Snip Out Dormant HIV from Cells– Philadelphia Enquirer, July 22, 2014 Genome Editing Cuts Out HIV– Scientist, July 21,…
For the seventh year, Treatment Action Group (TAG) and the Stop TB Partnership have published the latest investment data on the state of global tuberculosis (TB) research and development (R&D) funding.